Life ScienceCompany
Where is Flamingo Therapeutics headquartered?
Flamingo Therapeutics is headquartered in Leuven, Belgium.
What sector is Flamingo Therapeutics in?
Flamingo Therapeutics is a life science company.
Flamingo Therapeutics is headquartered in Leuven, Belgium.
Flamingo Therapeutics is a life science company.
Gaston Geenslaan 3,
Leuven,
3001
Belgium,
www.flamingotx.com
Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology with state-of-the art chemistries and a clinical-stage pipeline targeting undruggable transcription factors and splice variants. Flamingo Therapeutics has a Phase II trial (PEMDA-HN) evaluating the STAT3 targeting agent danvatirsen, in combination with pembrolizumab, in patients with head and neck squamous cell carcinoma (HNSCC). Flamingo Therapeutics is based in Leuven, Belgium.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | 1 | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.